Opinion: On regulation

Innovation is driven, in large part, by access to infrastructure -- if you can't make your own silicon chips, why should we worry about you making your own DNA?

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Rob Carlson had a piece recently in The Scientist on the linkurl:regulation of synthetic biology,;http://www.the-scientist.com/2011/1/1/24/1/ in part due to the supposed threat from the DIY Bio community. This seems to be part of a continuing hysterical exchange over a non-issue. While Carlson does not actively fear monger for dollars, as do others in the community, he does make statements that unfortunately continue to support a view of synthetic biology as a real-world discipline, as opposed to a collective fantasy.
Image: Wikimedia commons, Jacopo Werther
In particular, I take issue with the notion that "There is every reason to expect that garage innovation will be as important to biological technologies as it was to IT..." Without revisiting my usual diatribe over whether the term linkurl:'synthetic biology' is meaningless,;http://ellingtonlab.org/blog/2010/10/19/on-futures/ let's just look at the details of what is possible. Many of the constructs that folks who claim to be synthetic biologists make contain bacterial or eukaryotic promoters regulated by 'parts' such as the Lac and Tet repressors, which have been around for years. Many of these constructs could have as easily been made by PCR as by whole DNA synthesis. Many of the outcomes, whether for sensing or immune modulation, have already been embodied many times over in the literature in circuits known as 'plasmids.' Again, this comparison is not to necessarily point out the intellectual paucity of the field as to say: If much of this has been possible for over 30 years, then where exactly is the garage culture that is adding to innovation? Because I am a verified old person now, I remember my initial excitement with cloning, I remember talking with my peers about all the different things we could make, and I remember that we realized that we could maybe do it on our own...except that it would have been way too hard, compared to the just very hard day-to-day labors of a graduate student. The difference between DIY Bio and Michael Dell putting computers together in his garage is the difference between the availability of the raw materials. There is no 'Radio Shack' for DNA parts, and even if there were, the infrastructure required to manipulate those parts is non-trivial for all but the richest amateur scientist. And, yes, today I not only run my own DNA Fabrication Facility, where linkurl:we can build;http://ellingtonlab.org/blog/2010/07/01/on-fabs-and-dna-hacking-5/ out about 100 different 1 kilobase DNA chunks each week, I have in the past made a PCR machine from a hair dryer. I know what's possible, and I know what's likely, and I know what works. DIY Bio just plain doesn't work, and if it did, we would have had something worthwhile from the hobbyists long, long before this.There is going to be no stopping regulation, because there is no stopping ignorance. The community has crafted a fantasy construct, the idea that biology has an equivalent to integrated circuit boards (as opposed to breadboards); it has used this construct to fear monger for dollars; and now it gets to reap what it has sown. Various government agencies believe that synthetic biology exists, and that it has consequences different than biotechnology as a whole, and thus that it needs to be regulated. Forget that every grant proposal we put together to maintain our complicated infrastructure for doing synthetic biology has innumerable layers of regulation attached to it, we somehow need even more scrutiny to keep us from doing...what? Exactly what we said we were going to do in the grant proposal?But can we at least leave out this part of the conversation, the notion that there could be a black market because folks who hook up platinum electrodes to car batteries and pour agarose gels in Play Doh molds might someday actually create a bacterium that converts glucose to gold?linkurl:Andrew Ellington;http://f1000.com/thefaculty/member/409104261296178 is the Fraser Professor of Biochemistry at the University of Texas at Austin and an F1000 Member since 2001. This piece was adapted from linkurl:an entry on his blog,;http://ellingtonlab.org/blog/2011/01/23/on-regulation/ where he writes about biodefense and synthetic biology, although not necessarily in that order.
**__Related stories:__***linkurl:Opinion: On artificial proteins;http://www.the-scientist.com/news/display/57978/
[8th February 2011]*linkurl:Garage Innovation;http://www.the-scientist.com/2011/1/1/24/1/
[January 2011]*linkurl:Q&A: Ethics chair on synthetic biology;http://www.the-scientist.com/news/display/57816/
[19th November 2010]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrew Ellington

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development